Will Investment Sentiment Return to Bio Amid Tech Adjustment? KM Pharmaceutical and Lemon Healthc...
[Yu Jin-hee, Edaily Reporter] As the domestic stock market recently enters a breathing spell focused on semiconductors and key Information Technology (IT) stocks, investment sentiment is rapidly returning to the pharmaceutical and bio sectors.
In particular, a "medium-risk, high-return" preference is becoming distinct, centered on small and medium-sized stocks that have presented clear momentum such as top management’s strong commitment to stock price support, differentiated core technology, and proven financial turnarounds.
On the 30th, three pharmaceutical and bio companies made a strong entry into the Top 15 gainers list across the entire domestic stock market, clearly demonstrating this shift in the market structure.
뉴스픽의 주요 문장 추출 기술을 사용하여 “이데일리” 기사 내용을 3줄로 요약한 결과입니다. 일부 누락된 내용이 있어 전반적인 이해를 위해서는 본문 전체 읽기를 권장합니다.
